BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27216449)

  • 1. Diagnosis value of serum soluble B7-H4 expression in non-small cell lung cancer.
    Xu CH; Wang W; Wang YC; Lin Y; Zhang XW
    Clin Respir J; 2018 Jan; 12(1):134-139. PubMed ID: 27216449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of soluble H7-B4 in pleural effusion associated with lung cancer.
    Xu CH; Cao L; Zhang XW; Yan J; Yu LK
    Tumour Biol; 2015 Jun; 36(6):4397-403. PubMed ID: 25636447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer.
    Zhang G; Xu Y; Lu X; Huang H; Zhou Y; Lu B; Zhang X
    Lung Cancer; 2009 Nov; 66(2):245-9. PubMed ID: 19269710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
    Xu C; Qian L; Yu L; Zhang X; Wang Q
    Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
    Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
    Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer.
    Shi H; Ji M; Wu J; Zhou Q; Li X; Li Z; Zheng X; Xu B; Zhao W; Wu C; Jiang J
    World J Surg Oncol; 2014 Jun; 12():188. PubMed ID: 24947047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of serum B7-H4 for hepatocellular carcinoma.
    Zhang C; Li Y; Wang Y
    J Surg Res; 2015 Aug; 197(2):301-6. PubMed ID: 25963168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble B7-H4 blood serum levels are elevated in women at high risk for preeclampsia in the first trimester, as well as in patients with confirmed preeclampsia.
    Mach P; Nolte-Boenigk L; Droste L; Fox L; Frank M; Schmidt B; Herse F; Verlohren S; Wicherek L; Iannaccone A; Birdir C; Andrikos D; Kimmig R; Gellhaus A; Köninger A
    Am J Reprod Immunol; 2018 Sep; 80(3):e12988. PubMed ID: 29797540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging.
    Chen L; Zhang G; Sheng S; Zhou Q; Pan Y; Guan S
    Clin Chim Acta; 2016 Jun; 457():81-5. PubMed ID: 27071700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.
    Dong Q; Ma X
    Biomed Res Int; 2015; 2015():156432. PubMed ID: 25954746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus.
    Xiao JP; Wang XR; Zhang S; Wang J; Zhang C; Wang DG
    Iran J Immunol; 2019 Mar; 16(1):43-52. PubMed ID: 30864554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.
    Azuma T; Sato Y; Ohno T; Azuma M; Kume H
    PLoS One; 2018; 13(7):e0199719. PubMed ID: 30044793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of soluble B7-H4 in early pregnancy are elevated in women with preterm premature rupture of fetal membranes.
    Mach P; Köninger A; Wicherek L; Kimmig R; Kasimir-Bauer S; Birdir C; Schmidt B; Gellhaus A
    Am J Reprod Immunol; 2016 Aug; 76(2):149-54. PubMed ID: 27302185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
    Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
    Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
    Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
    Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of sB7-H4 in Serum and Lymphoma Tissues of Patients with Malignant Lymphoma and Its Value for Diagnosis and Re-Examine of Lymphoma].
    Liang XP; Yang HL; Shao MM; Li N; Li XF; Liu B; Li HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1355-1359. PubMed ID: 30295250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
    Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S
    J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
    Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of B7-H4 in non-small cell lung cancer.
    Wang W; Xu C; Wang Y; Yu L; Zhang X
    Biomarkers; 2016 Jun; ():1-16. PubMed ID: 27321138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.